RR

Rahul Rana

Investor, Solari Capital // CoS, SALT // Author, Making Moonshots

United States

Invests in

Stages:

  • Min Investment:

    $5,000.00
  • Max Investment:

    $50,000.00
  • Target Investment:

    $25,000.00

Work Experience

  • Associate

    2023

    Frontier Tech & Hard Sciences VC — Investing, Incubating, Fundraising + Ops, Admin. Doing it all. Associate & Chief of Staff to Founder/GP AJ Scaramucci. Deployed Funds I and II. Raising Fund III. Aerospace / Defense / Industrials: Apex Space, Northwood Space, Varda Space, Base Power, General Biological, Irradiant Technologies, Empirium AI: Contextual AI, Third Dimension AI, ViaVia Bio/Healthcare: Tessera Therapeutics, Path Health, Radial Health, MoldCo, Arcadia Medicines, Gameto, Prolific Machines, LincSwitch Therapeutics

2023

  • Chief of Staff

    2023

    Chief of Staff to President, Co-Chairman, & Managing Partner AJ Scaramucci. SALT is a capital introduction & thought leadership conference covering finance, science, technology, and geopolitics. We connect LPs (pensions, endowments, family offices, sovereign wealth funds, etc.) to GPs (VC, PE, HF, etc.). We currently host five annual events in NYC, Abu Dhabi, Singapore, Jackson Hole, and Davos that attract $15T of investable capital and 7,000+ attendees.

2022

  • Writer

    2022

    Writing about frontier tech & hard science sectors (https://www.notboring.co/) for 240,000+ subscribers. Made two scout investments for Not Boring Capital (Circa and Avro Life Science).

  • Author of "Making Moonshots"

    2020

    A deep-dive into the mindsets, philosophies, and strategies that are conducive to building moonshot companies. https://www.amazon.com/Making-Moonshots-Rahul-Rana/dp/163676620X

2022 - 2022

  • Investment Team

    2022 - 2022

    B2B Tech & Climate (BeyondNetZero) investment teams for General Atlantic, an $85bn global growth equity firm.

2021 - 2022

  • Translational Strategy

    2021 - 2022

    Arcadia is a frontier biotech lab and startup incubator. Raised $500m to help scientists commercialize their research into startups & build an internal 'moonshot company' factory. Reported to the CEO.

2020 - 2021

  • Venture Associate

    2020 - 2021

    Lux Capital ($5B AUM) invests in emerging science and technology ventures at the outermost edges of what is possible. We partner with iconoclastic inventors challenging the status quo and the laws of nature to bring their futuristic ideas to life. Worked under Managing Partner Josh Wolfe—investing, incubating, and portfolio company support.

2020 - 2020

  • Research and Content Intern

    2020 - 2020

    Researching, writing, and content creation // accepted into S21 Fellowship class

2020 - 2020

  • Business Operations

    2020 - 2020

    Business Development & Ops

2018 - 2018

  • Research Extern

    2018 - 2018

    Applied AI R&D projects